No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CTVA240517C55000
- 3.60
- +1.15+46.94%
15min DelayClose May 10 15:59 ET
3.60High3.48Low
3.60Open2.45Pre Close24 Volume555 Open Interest55.00Strike Price8.40KTurnover47.09%IV0.86%PremiumMay 17, 2024Expiry Date2.48Intrinsic Value100Multiplier5DDays to Expiry1.12Time Value100Contract SizeAmericanOptions Type0.7810Delta0.0852Gamma19.32Leverage Ratio-0.0933Theta0.0069Rho15.09Eff Leverage0.0217Vega
Intraday
- 5D
- 1D
News
11 Best Farmland and Agriculture Stocks To Buy According to Analysts
Express News | NYSE Order Imbalance 89208.0 Shares on Buy Side
Express News | NYSE Order Imbalance 93414.0 Shares on Buy Side
Form 144 | Corteva(CTVA.US) Officer Proposes to Sell 1.82 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Corteva(CTVA.US)$ Officer Eathington Samuel R intends to sell 31,686 shares of its common stock on May 9, with a total market value of approximately $1.82 million. S
Corteva(CTVA.US) Officer Sells US$687.34K in Common Stock
$Corteva(CTVA.US)$ Officer TITUS BRIAN sold 12,134 shares of common stock on May 6, 2024 at an average price of $56.6457 for a total value of $687.34K.Source: Announcement What is statement of changes
Corteva to Participate in the 2024 BMO Farm to Market Chemicals Conference
INDIANAPOLIS, May 8, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Executive Vice President and Chief Financial Officer, Dave Anderson, and Executive Vice President and Chief Technol
Comments
Morning Movers
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
26
1
Corteva's rising ROCE and efficient capital use are promising, but growing current liabilities may pose new risks. Despite this, the stock has given a decent 23% return over the past three years, indicating these developments are gaining deserved attention.
1
Corteva's high P/E ratio is sustained by its projected growth surpassing the broader market. Shareholders are at ease with the P/E, confident in the company's future earnings. The share price isn't anticipated to drop significantly soon under these conditions.
The CEO of Lavie Bio, Amit Noam, expressed satisfaction at achieving this milestone with Corteva, stating that the agreement showcases Lavie Bio's technological capabilities and enables the swift introduction of groundbreaking ag-biological solutions.
Corteva's guidance dispels concerns of lower earnings due to falling crop prices. Aptiv's 2024 forecast predicts a 7% sales growth despite stagnant global auto production. TD Cowen analyst Gautam Khanna deems Trane's results as 'good enough', rating the stock as Buy with a $235 price target.
Read more
Peanny : Based on Lies…. The truth is on its way.